EUVIMEDEUVIMED entdecken
Open Access

Alisma Shugan Decoction attenuates hepatic fibrosis and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis

Yun-Feng Sun, Hong-Hua Pan, Zhong-Ni Xia, Zhong-Min Yu, Cheng-Le Li, Xiao-Dong Wang, Sheng-Hui Shen

African Health Sciences · 2023

DOI: 10.4314/ahs.v23i2.49 ↗

Kurz gefasst

Fachartikel in der Zeitschrift African Health Sciences, 2023. Verfasst von Yun-Feng Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Academy of Traditional Chinese Medicine, Hangzhou 310007, Zhejiang Province, China. Hauptthemen laut MEDLINE: Carbon Tetrachloride, Alisma. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Over the years, Alisma Shugan Decoction (ASD), because of its potent anti-inflammation activity, has been used in traditional Chinese medicine (TCM) for treatment of many inflammation-associated disorders including those of the heart, blood vessel and brain.

Methods

Herein, we examined the probable therapeutic effect of ASD in carbon tetrachloride (CCl4)-induced liver injury and fibrosis mice models.

Results

Our results demonstrate that ASD dose-dependently reduced the fibrosis-related increased collagen deposition secondary to liver tissue exposure to CCl4. Data from our biochemical analyses showed significantly less liver damage biomarkers including ALT, AST and hydroxyproline in the ASD-treated samples, suggesting hepato-protective effect of ASD. Furthermore, we demonstrated that treatment with ASD significantly reversed CCl4-induced elevation of TNF-α, IL-6, IL-1β and MP-1. Interestingly, NF-κB signalling, a principal regulator of inflammation was markedly suppressed by ASD treatment. In addition, treatment with ASD deregulated stress signalling pathways by suppressing the expression of markers of unfolded protein response, such as ATF6, IRE and GRP78.

Conclusion

In conclusion, the present study provides preclinical evidence for the use of ASD as an efficacious therapeutic option in cases of chemical-induced liver damage and/or fibrosis. Further large-cohort validation of these findings is warranted. Keywords: Alisma Shugan Decoction; liver injury; fibrosis; anti-inflammation; unfolded protein response signalling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon TetrachlorideAlismaHumansRatsMiceAnimalsRats, Sprague-DawleyLiver CirrhosisLiverFibrosisInflammationEndoplasmic Reticulum Stress

Stichwörter der Autor:innen

Alisma Shugan Decoctionanti-inflammationfibrosisliver injuryunfolded protein response signalling

Substanzen

Carbon Tetrachloride

Autor:innen und Institutionen

  • Zhejiang Academy of Traditional Chinese Medicine, Hangzhou 310007, Zhejiang Province, China.
  • Department of Pharmacy, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang Province, China.

Zitieren

APA

Sun, Y. F., Pan, H. H., Xia, Z. N., Yu, Z. M., Li, C. L., Wang, X. D., & Shen, S. H. (2023). Alisma Shugan Decoction attenuates hepatic fibrosis and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis. African Health Sciences. https://doi.org/10.4314/ahs.v23i2.49

Vancouver

Sun YF, Pan HH, Xia ZN, Yu ZM, Li CL, Wang XD, et al. Alisma Shugan Decoction attenuates hepatic fibrosis and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis. African Health Sciences. 2023. doi:10.4314/ahs.v23i2.49

BibTeX
@article{Sun2023,
  author = {Sun, Yun-Feng and Pan, Hong-Hua and Xia, Zhong-Ni and Yu, Zhong-Min and Li, Cheng-Le and Wang, Xiao-Dong and Shen, Sheng-Hui},
  title = {Alisma Shugan Decoction attenuates hepatic fibrosis and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis},
  journal = {African Health Sciences},
  year = {2023},
  doi = {10.4314/ahs.v23i2.49}
}
Kostenlos starten →